[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567797":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":28,"locations":34,"responsibleParty":58,"collaborators":60,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":22,"eligibilityCriteria":71,"healthyVolunteers":67,"sex":72,"minAge":73,"maxAge":22,"enrollmentInfo":74,"targetDuration":22,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":22,"overallStatus":83,"whyStopped":22,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Kansas City Heart Rhythm Research Foundation","OTHER",[8,13],{"label":9,"type":6,"description":10,"interventionNames":11},"Newly diagnosed\u002Funtreated\u002Fincompletely treated for Cardiac Dysautonomia Patients","Newly diagnosed\u002Funtreated\u002Fincompletely treated for Cardiac Dysautonomia (Postural Orthostatic Tachycardia Syndrome (POTS), Inappropriate Sinus Tachycardia (IST), and Vasovagal syncope (VVS)) Patients",[12],"Other: Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)",{"label":14,"type":6,"description":15,"interventionNames":16},"Previously diagnosed\u002Ftreated\u002Fundergone sinus node modification for Cardiac Dysautonomia Patients","Previously diagnosed\u002Ftreated\u002Fpreviously undergone sinus node modification for Cardiac Dysautonomia Patients (Postural Orthostatic Tachycardia Syndrome (POTS), Inappropriate Sinus Tachycardia (IST), and Vasovagal syncope (VVS)) Patients",[12],[18],{"type":6,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)","To compare in patients with cardiac dysautonomia, newly developed disease specific questionnaire to established generalized SF-36 and EQ-5d questionnaires, as there are no disease specific questionnaires for comparison. These novel and established questionnaires will then be compared among groups who have relatively stable disease or stable symptoms with patients who will be expected to have a change in symptoms and QoL.",[9,14],null,[24],{"name":25,"affiliation":26,"role":27},"Dhanunjaya Lakkireddy","Kansas City Heart Rhythm Institute","PRINCIPAL_INVESTIGATOR",[29],{"name":30,"role":31,"phone":32,"phoneExt":22,"email":33},"Donita Atkins","CONTACT","816-651-1969","datkins@kchrf.com",[35,47,52],{"facility":26,"status":22,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":22},"Overland Park","Kansas","66211","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-94.67079,38.98223,{"lat":45,"lon":44},{"facility":48,"status":22,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":49,"geoPoint":51,"contacts":22},"Midwest Heart and Vascular Specialists",{"type":42,"coordinates":50},[44,45],{"lat":45,"lon":44},{"facility":53,"status":22,"city":36,"state":37,"zip":54,"country":39,"countryCode":40,"cosmosGeoPoint":55,"geoPoint":57,"contacts":22},"Overland Park Regional Medical Center","66215",{"type":42,"coordinates":56},[44,45],{"lat":45,"lon":44},{"type":59,"investigatorFullName":22,"investigatorTitle":22,"investigatorAffiliation":22,"oldNameTitle":22,"oldOrganization":22},"SPONSOR",[61,62],{"name":26,"class":6},{"name":63,"class":64},"Midwest Heart and Vascular Specialists, Overland Park, KS","UNKNOWN","100567797","development-and-validation-of-the-kansas-city-cardiac-dysautonomia-questionnaire-kcdysq-100567797",false,"NCT06672861","Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)","Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ) in Patients With Postural Orthostatic Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Other Disorders of Cardiac Dysautonomia","Inclusion criteria:\n\nPatients with a Diagnosis of POTS, IST, or vasovagal syncope\n\nExclusion criteria:\n\nPatients with comorbid chronic conditions causing significant impairments in quality of life, defined as:\n\n* NYHA Class III or IV Heart Failure\n* COPD GOLD 3 or 4, Group C or D\n* Any patients with current malignancy not in remission\n* Any patient with history of Autoimmune disease requiring chronic steroid therapy or immunomodulatory agents: Rheumatoid Arthritis, Lupus, Sarcoidosis, Psoriasis All patients with ESRD requiring hemodialysis All patients with cirrhosis of any origin Any patients with solid organ or bone marrow transplant requiring immunosuppressive therapy","ALL","18 Years",{"count":75,"type":76},100,"ESTIMATED","INTERVENTIONAL",[79],"NA","Main aim will be to compare in patients with cardiac dysautonomia, newly developed disease specific questionnaire to established generalized SF-36 and EQ-5d questionnaires, as there are no disease specific questionnaires for comparison. These novel and established questionnaires will then be compared among groups who have relatively stable disease or stable symptoms with patients who will be expected to have a change in symptoms and QoL.",[82],"Cardiac Dysautonomia","NOT_YET_RECRUITING","2025-08-27",{"date":86,"type":87},"2025-08-28","ACTUAL",{"date":89,"type":76},"2026-01",{"date":91,"type":76},"2026-08",{"name":5,"class":6},3]